2016
DOI: 10.1016/j.virusres.2015.11.025
|View full text |Cite
|
Sign up to set email alerts
|

Antibody titers against vaccine and contemporary wild poliovirus type 1 in children immunized with IPV + OPV and young adults immunized with OPV

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…This virus differed from the corresponding Sabin strain by over 17% nucleotide sequence of VP1. Taking into account that poliovirus accumulates about 1% substitutions in VP1 per year [19], it is most likely that this virus was excreted by an immunodeficient vaccine recipient (or a contact of an OPV recipient), since such a long-term circulation of VDPV in a highly immunized population [25] is unlikely, although it cannot be completely excluded. It is noteworthy that a targeted search for persisting polioviruses in immunocompromised children, which are a risk group for preserving divergent viruses, was carried out in Russia, including Moscow, in 2008–2013 (136 enrolled patients) [26] and in 2014–2015 (83 enrolled patients) [27].…”
Section: Discussionmentioning
confidence: 99%
“…This virus differed from the corresponding Sabin strain by over 17% nucleotide sequence of VP1. Taking into account that poliovirus accumulates about 1% substitutions in VP1 per year [19], it is most likely that this virus was excreted by an immunodeficient vaccine recipient (or a contact of an OPV recipient), since such a long-term circulation of VDPV in a highly immunized population [25] is unlikely, although it cannot be completely excluded. It is noteworthy that a targeted search for persisting polioviruses in immunocompromised children, which are a risk group for preserving divergent viruses, was carried out in Russia, including Moscow, in 2008–2013 (136 enrolled patients) [26] and in 2014–2015 (83 enrolled patients) [27].…”
Section: Discussionmentioning
confidence: 99%
“…In 2010, a poliomyelitis outbreak was caused by a wild PV1 in Congo with a unique and consequential mutation signature (PV1-RC2010), resulting in 445 deaths with 47% mortality [30]. Later serological studies reported that 15-29% of individuals vaccinated with IPVs in Germany and 15-50% of individuals vaccinated with OPVs and/or IPVs in Russia were seronegative against this PV1-RC2010 strain, though 100% of them in Germany and 92-96% of them in Russia were seropositive against Sabin or wild PV1 vaccine strains [31,32]. Further, a smaller scale serological study in the US tested a panel of wild and vaccine-derived PV1 against 26 sera from vaccine-immunized healthy individuals: despite a significant reduction in nAb against PV1 strains that were immunologically different from the vaccine strain, especially with only 54% seropositive rate against PV1-RC2010, administration of a booster dose of IPV restored nAb against all strains [33].…”
Section: Discussionmentioning
confidence: 99%